Schedule 13G ownership disclosure

NEWLINK GENETICS CORP

Security class unavailable · CUSIP: 651511107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,061,013
Percent of class
5.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-19-000065
Form type
SC 13G
Filer
LUMOS PHARMA, INC.
CIK
CIK 1126234
Filed
Feb 12, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub